|
When launching or repositioning a product for the marketplace, the strategic support that PR provides in connection with clinical, regulatory, and marketing milestones is critical to successful life-cycle planning.
A well-engineered PR effort will result in
- A highly integrated set of activities that will create sustainable marketplace advantage
- Superior financial returns to clients
Whether PR is used for a new drug entity, corporate portfolio, or late-life compounds, Convergence seeks to create favorable brand and corporate awareness, advocacy, and sales through earned media. All activities are also planned in coordination with medical education, professional promotion, and direct-to-consumer advertising.
››› Strategic Media Relations
|
